Year |
Citation |
Score |
2016 |
Tisi D, Chiarparin E, Tamanini E, Pathuri P, Coyle JE, Hold A, Holding FP, Martin AC, Rich SJ, Berdini V, Yon J, Acklam P, Burke R, Drouin L, Harmer JE, et al. Structure of the Epigenetic Oncogene MMSET & Inhibition by N-Alkyl Sinefungin Derivatives. Acs Chemical Biology. PMID 27571355 DOI: 10.1021/Acschembio.6B00308 |
0.329 |
|
2009 |
Pathuri P, Nguyen ET, Ozorowski G, Svärd SG, Luecke H. Apo and calcium-bound crystal structures of cytoskeletal protein alpha-14 giardin (annexin E1) from the intestinal protozoan parasite Giardia lamblia. Journal of Molecular Biology. 385: 1098-112. PMID 19046974 DOI: 10.1016/J.Jmb.2008.11.012 |
0.652 |
|
2008 |
Pathuri P, Vogeley L, Luecke H. Crystal structure of metastasis-associated protein S100A4 in the active calcium-bound form. Journal of Molecular Biology. 383: 62-77. PMID 18783790 DOI: 10.1016/J.Jmb.2008.04.076 |
0.499 |
|
2007 |
Pathuri P, Nguyen ET, Svärd SG, Luecke H. Apo and calcium-bound crystal structures of Alpha-11 giardin, an unusual annexin from Giardia lamblia. Journal of Molecular Biology. 368: 493-508. PMID 17355882 DOI: 10.1016/J.Jmb.2007.02.016 |
0.714 |
|
2006 |
Pathuri P, Nguyen ET, Luecke H. Expression, purification, crystallization and preliminary X-ray diffraction analysis of alpha-11 giardin from Giardia lamblia. Acta Crystallographica. Section F, Structural Biology and Crystallization Communications. 62: 1108-12. PMID 17077490 DOI: 10.1107/S1744309106039650 |
0.675 |
|
Low-probability matches (unlikely to be authored by this person) |
2012 |
Saalau-Bethell SM, Woodhead AJ, Chessari G, Carr MG, Coyle J, Graham B, Hiscock SD, Murray CW, Pathuri P, Rich SJ, Richardson CJ, Williams PA, Jhoti H. Discovery of an allosteric mechanism for the regulation of HCV NS3 protein function. Nature Chemical Biology. 8: 920-5. PMID 23023261 DOI: 10.1038/nchembio.1081 |
0.266 |
|
2013 |
Pathuri P, Norton D, Willems H, Tisi D, Jhoti H. Structural Biology and Anticancer Drug Design Cancer Drug Design and Discovery: Second Edition. 121-141. DOI: 10.1016/B978-0-12-396521-9.00004-8 |
0.153 |
|
2011 |
Pathuri P, Chessari G, Carr MG, Congreve M, Coyle JE, Day PJ, Fazal L, Frederickson M, Graham B, Lewis J, McMenamin R, Murray CW, O'Brien AM, Patel S, Williams G, et al. Fragment-based drug discovery applied to heat shock protein 90 (HSP90) Acta Crystallographica Section a Foundations of Crystallography. 67: C303-C303. DOI: 10.1107/S0108767311092415 |
0.128 |
|
2012 |
Pathuri P, Saalau-Bethell SM, Woodhead AJ, Carr MG, Chessari G, Coyle J, Frederickson M, Graham B, Hamlett C, Hiscock SD, Holding FP, Jhoti H, McMenamin R, Murray CW, Reader M, et al. Discovery of novel allosteric inhibitors of HCV NS3/4a enzyme via structure-based drug design Acta Crystallographica Section a Foundations of Crystallography. 68: s27-s27. DOI: 10.1107/S0108767312099473 |
0.114 |
|
2013 |
Howard S, Amin N, Benowitz AB, Chiarparin E, Cui H, Deng X, Heightman TD, Holmes DJ, Hopkins A, Huang J, Jin Q, Kreatsoulas C, Martin AC, Massey F, McCloskey L, ... ... Pathuri P, et al. Fragment-based discovery of 6-azaindazoles as inhibitors of bacterial DNA ligase. Acs Medicinal Chemistry Letters. 4: 1208-12. PMID 24900632 DOI: 10.1021/ml4003277 |
0.105 |
|
2021 |
Heightman TD, Berdini V, Bevan L, Buck IM, Carr MG, Courtin A, Coyle JE, Day JEH, East C, Fazal L, Griffiths-Jones CM, Howard S, Kucia-Tran J, Martins V, Muench S, ... ... Pathuri P, et al. Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2. Journal of Medicinal Chemistry. PMID 34387469 DOI: 10.1021/acs.jmedchem.1c00905 |
0.095 |
|
2015 |
Pathuri P, Saalau-Bethell SM, Woodhead AJ, Berdini V, Carr MG, Chessari G, Cleasby A, Congreve M, Coyle JE, Graham B, Hiscock SD, Lock V, Murray CW, O'Brien MA, Rich SJ, et al. Identification of novel allosteric inhibitors through fragment-based drug discovery and X-ray crystallography Acta Crystallographica Section a Foundations and Advances. 71: s38-s38. DOI: 10.1107/S2053273315099398 |
0.081 |
|
2018 |
Heightman TD, Berdini V, Braithwaite H, Buck IM, Cassidy M, Castro J, Courtin A, Day JEH, East C, Fazal L, Graham B, Griffiths-Jones CM, Lyons JF, Martins V, Muench S, ... ... Pathuri P, et al. Fragment-based discovery of a potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2. Journal of Medicinal Chemistry. PMID 29775310 DOI: 10.1021/Acs.Jmedchem.8B00421 |
0.078 |
|
2024 |
Woodhead AJ, Erlanson DA, de Esch IJP, Holvey RS, Jahnke W, Pathuri P. Fragment-to-Lead Medicinal Chemistry Publications in 2022. Journal of Medicinal Chemistry. PMID 38289623 DOI: 10.1021/acs.jmedchem.3c02070 |
0.067 |
|
2012 |
Wilsher N, Saalau-Bethell S, Woodhead A, Millemaggi A, Graham B, Hamlett C, Murray C, Norton D, Rees D, Chiarparin E, Willems H, Lewis J, Fazal L, Carr M, Hodder M, ... ... Pathuri P, et al. 878 PRE-CLINICAL CHARACTERISATION OF A NOVEL DIRECT ACTING ANTIVIRAL AGENT WITH A NEW MODE OF ACTION Journal of Hepatology. 56: S342. DOI: 10.1016/S0168-8278(12)60890-3 |
0.043 |
|
Hide low-probability matches. |